CareWear Wearable Light products have been approved to treat injuries
through a growing number of workers’ compensation programs in professional sports.
Thousands of athletes are injured during sports participation– with sprains, strains, tendinopathies and contusions being the most common – and need effective treatment for pain associated with these injuries.
Over the past decade there has been a dramatic increase in the use of opioids to treat musculoskeletal pain, despite a lack of evidence to support this practice.
Current practice guidelines caution against the use of early opioid treatment due to longer disability, higher medical costs, greater risk of surgery and long-term opioid use.
What is needed are effective treatments for pain which are safe, easy-to-use, and supported by published research.
Photobiomodulation (PBM), formally known as low-level laser/light, has been shown to reduce inflammation and edema, induce analgesia, and promote healing in a range of musculoskeletal pathologies.
PBM is recommended by evidence-based clinical guidelines in neck, low back and carpal tunnel as well as numerous systematic reviews on acute, chronic, musculoskeletal, and neuropathic pain; tendinopathies, plantar fasciitis, fibromyalgia, and TMJ. Research also supports applications in ankle sprain as well as tissue and muscle recovery.
To begin addressing this need, several workers’ compensation programs in professional sports have approved CareWear Wearable Light products to treat athlete injuries in the National Football League (NFL), Major League Baseball (MLB), Major League Soccer (MLS), East Coast Hockey League (ECHL) and the National Women’s Soccer League (NWSL). Athletes can also purchase CareWear products directly on our website using their Mastercard® or Visa® payment cards provided by their HSA/MSA health plans.
Please contact us for additional updates and information, as the number of workers’ compensation providers offering CareWear Wearable Light products continues to grow.